Cstone Pharmaceuticals Ownership
HK$5.34
0.74%
Hong Kong, Sep 18, 04:00 pm HKT.
Closed.
ISIN
KYG2588M1006
Symbol
2616
Industry
Cstone Pharmaceuticals Top Shareholders
| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
WuXi Healthcare Management, LLC
|
173.381m | 11.75% | — | Apr 22 2026 |
| 2 |
Pfizer Corporation Hong Kong Ltd.
|
115.929m | 7.85% | — | Apr 22 2026 |
| 3 |
HHLR Advisors, Ltd.
|
88.665m | 6.01% | +88.665m | Apr 15 2026 |
| 4 |
GIC Private Limited
|
76.041m | 5.15% | -27.194m | Apr 22 2026 |
| 5 |
Boyu Capital Holdings Ltd
|
40.018m | 2.71% | -93.343m | Jun 10 2025 |
|
1
WuXi Healthcare Management, LLC
|
11.75%
173.381m
|
|
2
Pfizer Corporation Hong Kong Ltd.
|
7.85%
115.929m
|
|
3
HHLR Advisors, Ltd.
|
6.01%
88.665m
|
|
4
GIC Private Limited
|
5.15%
76.041m
|
|
5
Boyu Capital Holdings Ltd
|
2.71%
40.018m
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 33.47% of Cstone Pharmaceuticals, with WuXi Healthcare Management, LLC the biggest at 11.75%, followed by Pfizer Corporation Hong Kong Ltd. (7.85%) and HHLR Advisors, Ltd. (6.01%). |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
